CITATION: Mugendi, G. A. et al. 2014. Calcium channel blockers for people with chronic kidney disease requiring dialysis. Cochrane Database of Systematic Reviews, 4:CD011064, doi:10.1002/14651858.CD011064.The original publication is available at https://www.cochranelibrary.comThis is the protocol for a review and there is no abstract. The objectives are as follows: This review aims to look at the benefits and harms of CCB for people with CKD requiring dialysis.Publisher's versio
Background: Vitamin D compounds are used to suppress elevated serumparathyroid hormone (PTH) in peop...
Background: Decline in estimated Glomerular filtration rate (eGFR) is associated with further prog...
Chronic kidney disease (CKD) is a worldwide health problem. The disease is most often progressive of...
Background: Calcium channel blockers (CCBs) are used to manage hypertension which is highly prevalen...
Background: Calcium channel blockers (CCBs) are used to manage hypertension which is highly prevalen...
Background: Chronic kidney disease (CKD) is an emerging health problem and is one of the major cause...
Background: Chronic kidney disease is defined as abnormalities in kidney structure and function, pre...
Background: CKD (chronic kidney disease) is a general term for heterogeneous disorders affecting kid...
Background: Decline in estimated Glomerular filtration rate (eGFR) is associated with further progre...
Aim: To evaluate the effectiveness of contrast-induced acute kidney injury (CI-AKI) prophylaxis retr...
Background: Vitamin D compounds are used to suppress elevated serumparathyroid hormone (PTH) in peop...
Objective: Hypertension (HTN) is both a cause and an effect of chronic kidney disease (CKD). To adeq...
Role of combination therapy with ACE inhibitors and calcium channel blockers in renal protection.Ove...
Cinacalcet versus standard treatment for chronic kidney disease: a protocol for a systematic review ...
Background. Limited data exist on whether the cardiopro-tective benefit of β-blockers is modified by...
Background: Vitamin D compounds are used to suppress elevated serumparathyroid hormone (PTH) in peop...
Background: Decline in estimated Glomerular filtration rate (eGFR) is associated with further prog...
Chronic kidney disease (CKD) is a worldwide health problem. The disease is most often progressive of...
Background: Calcium channel blockers (CCBs) are used to manage hypertension which is highly prevalen...
Background: Calcium channel blockers (CCBs) are used to manage hypertension which is highly prevalen...
Background: Chronic kidney disease (CKD) is an emerging health problem and is one of the major cause...
Background: Chronic kidney disease is defined as abnormalities in kidney structure and function, pre...
Background: CKD (chronic kidney disease) is a general term for heterogeneous disorders affecting kid...
Background: Decline in estimated Glomerular filtration rate (eGFR) is associated with further progre...
Aim: To evaluate the effectiveness of contrast-induced acute kidney injury (CI-AKI) prophylaxis retr...
Background: Vitamin D compounds are used to suppress elevated serumparathyroid hormone (PTH) in peop...
Objective: Hypertension (HTN) is both a cause and an effect of chronic kidney disease (CKD). To adeq...
Role of combination therapy with ACE inhibitors and calcium channel blockers in renal protection.Ove...
Cinacalcet versus standard treatment for chronic kidney disease: a protocol for a systematic review ...
Background. Limited data exist on whether the cardiopro-tective benefit of β-blockers is modified by...
Background: Vitamin D compounds are used to suppress elevated serumparathyroid hormone (PTH) in peop...
Background: Decline in estimated Glomerular filtration rate (eGFR) is associated with further prog...
Chronic kidney disease (CKD) is a worldwide health problem. The disease is most often progressive of...